My most recent interview is with Gavin Nichols, the CEO of the newly formed company Velsera. Velsera launched in January 2023, after quietly acquiring the three companies Seven Bridges, UgenTec, and Pierian in mid...read more
We may still be five Years out until We Can Sequence Everyone I had the chance to attend the Precision Medicine World Conference PMWC 2023 SV in the last couple of days. Some 2,000+ individuals from across the life...read more
We say goodbye to 2022 which was full of significant developments in the life sciences, precision medicine, genetics, and genomics sectors. Notable new players in the next-generation sequencing field showcased their...read more
enlightenbio provides a conduit between research and related technical and analytical resources. We are dedicated to communicating in the researcher’s language, identifying unmet needs, and understanding product development requirements. Our goals are aligned with the needs of healthcare professionals and organizations to increase productivity and technology development and adaption, and to make sense of the resulting biological data.
Copyright © 2023. enlighenbio LLC. All rights reserved.
Your Header Sidebar area is currently empty. Hurry up and add some widgets.